
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $134.9M | -- | -- | $0.15 | -- |
08/07/2025 | Q2 | $123.5M | -- | -- | $0.15 | -- |
05/08/2025 | Q1 | $118.4M | $119.1M | -$0.01 | $0.12 | -$0.13 |
02/27/2025 | Q4 | $121.4M | $121.6M | -$0.05 | $0.10 | -$0.15 |
11/07/2024 | Q3 | $136.1M | $137.7M | -$0.04 | $0.10 | -$0.14 |
08/08/2024 | Q2 | $125M | $127.4M | -$0.12 | $0.09 | -$0.21 |
05/09/2024 | Q1 | $123.3M | $124.2M | -$0.10 | $0.09 | -$0.19 |
02/29/2024 | Q4 | $134.6M | $135.1M | $0.01 | $0.08 | -$0.07 |
11/09/2023 | Q3 | -- | -- | -$0.01 | $0.07 | -$0.08 |
08/10/2023 | Q2 | -- | -- | -$0.08 | $0.04 | -$0.12 |
05/11/2023 | Q1 | -- | -- | -$0.16 | -$0.05 | -$0.11 |
03/07/2023 | Q4 | -- | -- | -$0.25 | -$0.10 | -$0.15 |
11/08/2022 | Q3 | -- | -- | -$0.16 | -$0.13 | -$0.03 |
08/09/2022 | Q2 | -- | -- | -$0.13 | -$0.06 | -$0.07 |
05/10/2022 | Q1 | -- | -- | -$0.10 | -$0.03 | -$0.07 |
03/01/2022 | Q4 | -- | -- | -$0.08 | -$0.04 | -$0.04 |
11/09/2021 | Q3 | -- | -- | -$0.18 | -$0.14 | -$0.04 |
08/04/2021 | Q2 | -- | -- | -$0.28 | -- | -- |
05/05/2021 | Q1 | -- | -- | -$0.13 | -- | -- |
02/23/2021 | Q4 | -- | -- | -$0.19 | -- | -- |
11/05/2020 | Q3 | -- | -- | -$0.22 | -- | -- |
08/05/2020 | Q2 | -- | -- | -$0.38 | -- | -- |
05/11/2020 | Q1 | -- | -- | -$0.51 | -- | -- |
02/24/2020 | Q4 | -- | -- | $0.26 | -- | -- |
11/07/2019 | Q3 | -- | -- | -$0.41 | -- | -- |
08/06/2019 | Q2 | -- | -- | -$0.45 | -- | -- |
04/30/2019 | Q1 | -- | -- | -$0.55 | -- | -- |
02/05/2019 | Q4 | -- | -- | -$0.43 | -- | -- |
10/25/2018 | Q3 | -- | -- | -$0.19 | -- | -- |
08/27/2018 | Q2 | -- | -- | -$0.25 | -- | -- |
03/31/2018 | Q1 | -- | -- | -$0.07 | -- | -- |
12/31/2017 | Q4 | -- | -- | $0.04 | -- | -- |
09/30/2017 | Q3 | -- | -- | $0.08 | -- | -- |
06/30/2017 | Q2 | -- | -- | -$0.03 | -- | -- |
03/31/2017 | Q1 | -- | -- | $0.00 | -- | -- |
Arlo Technologies reported $119.1M worth of top line sales in its most recent quarter.
Arlo Technologies announced earnings per share of -$0.01 which represents a miss of analyst forecast a $0.12 per share.
Arlo Technologies reported $52.7M that represents $0.52 per share over the last quarter.
Arlo Technologies's earnings are forecast to decrease from -$0.31 per share to $0.41 per share next year representing a decrease of -95.44%.
Arlo Technologies's next earnings date is August 7, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.